Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Total Non-Current Liabilities (2022 - 2023)

TransMedics has reported Total Non-Current Liabilities over the past 2 years, most recently at $562.8 million for Q3 2023.

  • Quarterly results put Total Non-Current Liabilities at $562.8 million for Q3 2023, changed N/A from a year ago — trailing twelve months through Sep 2023 was $562.8 million (changed N/A YoY), and the annual figure for FY2022 was $89.8 million, changed.
  • Total Non-Current Liabilities for Q3 2023 was $562.8 million at TransMedics, up from $545.1 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for TMDX hit a ceiling of $562.8 million in Q3 2023 and a floor of $89.8 million in Q4 2022.